France Veterinary Contract Manufacturing & Research Market (2026-2031)
The France Veterinary Contract Manufacturing & Research Market was valued at $54.4 Million in 2026 and projected to reach to $78.6 Million by 2031, representing a compound annual growth rate of 7.7%. France's veterinary contract manufacturing and research market is poised for sustained expansion, driven by increasing outsourcing trends among European pharmaceutical companies and rising investments in animal health innovation.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France Veterinary Contract Manufacturing & Research Market Trends and Insights
- France has established itself as a key hub for veterinary pharmaceutical development and manufacturing within Europe, driven by robust regulatory frameworks and advanced research infrastructure.
- The market in France benefits from strong demand for specialized contract research organization (CRO) services and manufacturing capabilities tailored to veterinary biologics and pharmaceuticals. Growth in France's veterinary contract manufacturing sector is underpinned by increasing investment in animal health innovation, rising prevalence of companion animal diseases, and stringent quality standards that necessitate outsourced expertise.
- France's position within the European Union provides access to harmonized regulatory pathways and cross-border collaboration opportunities.
- Between 2026 and 2031, France is expected to capture growing market share as domestic and international pharmaceutical companies expand their veterinary R&D and manufacturing footprints in the region..
Key Market Statistics
- CAGR (2026-2031) 7.7% CAGR
- Market Size, 2026 ~USD 54.4 Million
- Forecast, 2031 ~USD 78.6 Million
- Country France
France Veterinary Contract Manufacturing & Research Market Overview
Market Valuation :
France's veterinary contract manufacturing and research market is valued at USD 54.4 million in 2026, with strong growth trajectory positioning it as a significant European hub for veterinary pharmaceutical services.
Regulatory Excellence :
France benefits from robust European regulatory frameworks and stringent quality standards that attract international pharmaceutical companies seeking compliant contract manufacturing and research partnerships.
Research Infrastructure :
Advanced research facilities and specialized laboratories across France support innovative veterinary drug development, clinical trials, and bioanalytical services for domestic and international clients.
Growth Momentum :
With a projected CAGR of 7.7% through 2031, reaching USD 78.6 million, France's market reflects increasing demand for outsourced veterinary pharmaceutical development and manufacturing services.
France Veterinary Contract Manufacturing & Research Market Dynamics
- The country's established regulatory infrastructure and skilled workforce position it as a preferred destination for contract research organizations and manufacturing partners seeking European compliance and quality assurance. Growing demand for specialized veterinary formulations, biologics, and generic medications will further accelerate market growth.
- Strategic partnerships between French CROs and international pharmaceutical firms, combined with advancements in manufacturing technologies and regulatory harmonization within the EU, will create additional opportunities for market participants through 2031..
Related Ecosystem
Animal Health
Key Takeaways
- France's veterinary contract manufacturing & research market is valued at USD 54.4 million in 2026 and will reach USD 78.6 million by 2031.
- France maintains a 7.7% CAGR, reflecting steady demand for outsourced veterinary pharmaceutical development and manufacturing services.
- France's EU membership and regulatory harmonization create competitive advantages for contract manufacturers serving pan-European veterinary markets.
- Rising companion animal healthcare spending and innovation in veterinary biologics are key growth drivers for France's contract manufacturing sector.
Veterinary Contract Manufacturing & Research Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CDMO SERVICES (Service) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.7% from 2026 to 2031 |
| Largest Segment | CDMO SERVICES (Service) |
| Market Size Base Year (Billions) | ~USD 6.38 (2026) |
| Revenue Forecast (Billions) | ~USD 9.24 (2031) |
| Segments Covered | Service, Type |
France Veterinary Contract Manufacturing & Research Market Report Segmentation
2 segment dimensions are covered across the global market.
By Service
- Cdmo Services
- Cro Services
By Type
- Analytical & Bioanalytical Services And Quality Assurance
- Discovery & Pre-Clinical Studies
- Manufacturing
- Packaging & Labeling
- Process Api & Formulation Development
- Quality/Stability & Post-Market Support
- Regulatory Affairs & Consulting
- Veterinary Clinical Trials
FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS | 19.7 | 21.3 | 22.9 | 24.8 | 26.8 | 28.9 | 31.2 | 33.7 | 8 |
| MULTINATIONAL ANIMAL HEALTH COMPANIES | 20.7 | 21.9 | 23.3 | 24.7 | 26.2 | 27.8 | 29.6 | 31.4 | 6.2 |
| START-UPS & VETERINARY BIOTECH FIRMS | 6.7 | 7.4 | 8.2 | 9 | 10 | 11.1 | 12.2 | 13.5 | 10.6 |
| TOTAL | 47.1 | 50.6 | 54.4 | 58.5 | 63 | 67.8 | 73 | 78.6 | 7.7 |
Target Audience
- Contract Research Organizations (CROs) : CROs need France-specific market data to assess expansion opportunities, benchmark service offerings, and identify client acquisition strategies within the growing French veterinary pharmaceutical sector.
- Pharmaceutical & Biotech Companies : Pharmaceutical firms require detailed France market insights to evaluate outsourcing partnerships, identify local CRO capabilities, and optimize their veterinary drug development and manufacturing strategies.
- Manufacturing & Facility Operators : Contract manufacturers need France-specific demand forecasts and market trends to plan capacity investments, service expansion, and competitive positioning in the European veterinary market.
- Investment & Private Equity Firms : Investors require comprehensive France market analysis to evaluate acquisition targets, assess growth potential, and make informed decisions on veterinary healthcare service investments.
- Regulatory & Compliance Consultants : Consultants need France-specific regulatory insights and market dynamics to advise clients on market entry strategies, compliance requirements, and partnership development in the veterinary sector.
Reasons to Buy this Report
- Market-Specific Sizing & Forecasts : Access precise valuation data for France's veterinary contract manufacturing market (USD 54.4M in 2026, USD 78.6M in 2031) with country-specific CAGR analysis to support investment and expansion decisions.
- Regulatory & Compliance Insights : Understand France's unique regulatory landscape, quality standards, and compliance requirements that differentiate it from other European markets and impact service delivery and partnership strategies.
- Competitive Landscape Analysis : Identify key players, market consolidation trends, and competitive positioning specific to France's veterinary CRO and manufacturing sectors to inform market entry and partnership strategies.
- Growth Driver Identification : Discover France-specific growth catalysts including outsourcing adoption rates, pharmaceutical company investments, and emerging therapeutic areas driving demand for contract services.
- Strategic Partnership Opportunities : Leverage detailed market intelligence to identify potential acquisition targets, joint venture partners, and collaboration opportunities within France's veterinary pharmaceutical ecosystem.
Frequently asked questions
What is the current market size of veterinary contract manufacturing in France?
France's veterinary contract manufacturing and research market is valued at USD 54.4 million in 2026.
What is the projected market size for France by 2031?
France's veterinary contract manufacturing market is forecast to reach USD 78.6 million by 2031.
What is the growth rate for France's veterinary contract manufacturing market?
France's veterinary contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2031.
What factors are driving growth in France's veterinary contract manufacturing sector?
Key drivers include increasing investment in animal health innovation, rising companion animal disease prevalence, stringent quality standards, and France's advantageous position within the EU regulatory framework.
Why is France an important market for veterinary contract manufacturing?
France offers advanced research infrastructure, robust regulatory frameworks, EU regulatory harmonization, and access to cross-border collaboration opportunities that attract domestic and international veterinary pharmaceutical companies.
RESEARCH METHODOLOGY
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product/service managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.
Market Definition
The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.
These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.
Key Stakeholders
- Animal-health pharmaceutical companies
- Veterinary biotechnology companies
- Veterinary biologics & vaccine developers
- Veterinary contract development & manufacturing organizations (CDMOs)
- Veterinary contract research organizations (CROs)
- Preclinical & toxicology research laboratories (GLP & non-GLP)
- Clinical trial management organizations for veterinary studies
- Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
- Quality control & analytical testing laboratories (veterinary-focused)
- Veterinary formulation & process development service providers
- Packaging, filling, and labeling service providers for veterinary products
- Animal research facilities & field trial centers
- Veterinary academic research institutes
- Livestock research institutions & herd-health trial networks
- Raw material suppliers for veterinary APIs, excipients, and biologics components
Report Objectives
- To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
- Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
- Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
- Competitive leadership mapping for established players in the US
Get the Full Veterinary Contract Manufacturing & Research Market Report
Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.
- US Veterinary Contract Manufacturing & Research Market
- Canada Veterinary Contract Manufacturing & Research Market
- Mexico Veterinary Contract Manufacturing & Research Market
- Brazil Veterinary Contract Manufacturing & Research Market
- Argentina Veterinary Contract Manufacturing & Research Market
- Germany Veterinary Contract Manufacturing & Research Market
- UK Veterinary Contract Manufacturing & Research Market
- Italy Veterinary Contract Manufacturing & Research Market
- Spain Veterinary Contract Manufacturing & Research Market
- Netherlands Veterinary Contract Manufacturing & Research Market
- China Veterinary Contract Manufacturing & Research Market
- Japan Veterinary Contract Manufacturing & Research Market
- India Veterinary Contract Manufacturing & Research Market
- Australia Veterinary Contract Manufacturing & Research Market
- South Korea Veterinary Contract Manufacturing & Research Market
- Thailand Veterinary Contract Manufacturing & Research Market
- New Zealand Veterinary Contract Manufacturing & Research Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report